CAS 1228585-88-3

4-Amino-2-butoxy-7,8-dihydro-8-[[3-(1-pyrrolidinylmethyl)phenyl]methyl]-6(5H)-pteridinone

CAS: 1228585-88-3

Formula: C₂₂H₃₀N₆O₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 410.5126

Ref: IN-DA003ATZ

Vesatolimod

CAS: 1228585-88-3

Vesatolimod

Formula: C₂₂H₃₀N₆O₂

Purity: ≥95%

Molecular weight: 410.51

Ref: 54-BUP06322

4-Amino-2-Butoxy-8-(3-(Pyrrolidin-1-Ylmethyl)Benzyl)-7,8-Dihydropteridin-6(5H)-One

CAS: 1228585-88-3

4-Amino-2-Butoxy-8-(3-(Pyrrolidin-1-Ylmethyl)Benzyl)-7,8-Dihydropteridin-6(5H)-One

Formula: C₂₂H₃₀N₆O₂

Purity: 98%

Molecular weight: 410.52

Ref: 54-OR1024202

Vesatolimod

CAS: 1228585-88-3

Vesatolimod (GS-9620) is an effective and specific orally active agonist of Toll-like receptor 7.

Formula: C₂₂H₃₀N₆O₂

Purity: 97.46% - 99.03%

Color and Shape: Solid

Molecular weight: 410.51

Ref: TM-T6846

GS 9620

CAS: 1228585-88-3

GS 9620 is a prodrug that is converted to its active form, GS-9669, in the liver. The conversion of GS-9620 to GS-9669 is catalyzed by cytochrome P450 (CYP) family 3A4 and 2D6 enzymes. GS-9620 has been shown to reduce hepatic steatosis in mice with chronic viral hepatitis and can be used as an adjunct therapy with other antiretroviral drugs for HIV infection. GS-9620 has antiviral activity against a variety of viruses including HIV, hepatitis B virus, and hepatitis C virus. It also inhibits the activation of toll-like receptors that are involved in inflammation.

Formula: C₂₂H₃₀N₆O₂

Purity: Min. 95%

Color and Shape: Solid

Molecular weight: 410.51 g/mol

Ref: 3D-FG146405

Vesatolimod

CAS: 1228585-88-3

4-Amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5H)-one

Formula: C₂₂H₃₀N₆O₂

Purity: 98%

Molecular weight: 410.51

Ref: IN-DG254187

Vesatolimod

CAS: 1228585-88-3

Purity: 98%

Molecular weight: 410.522

Ref: 10-F979625